Prevention of bone resorption
US5674887A · kind A · utility
3Cited by
2References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 22, 1995 |
| Grant date | Oct 7, 1997 |
| Priority date | — |
| Expiry date | Feb 22, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The administration of a xanthine oxidase inhibitor is effective for the treatment or prevention of the excessive resorption of bone in conditions such as osteoporosis and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.